Procurement Report: Finasteride 5mg Tablets

Product Category: Pharmaceutical Active Pharmaceutical Ingredient (API) / Finished Dosage Form (Tablets) Primary Indication: Benign Prostatic Hyperplasia (BPH) and Androgenetic Alopecia (Hair Loss) Active Ingredient: Finasteride Standard Dosage: 5 mg

---

1. Technical Specifications and Performance Metrics

Finasteride 5mg tablets are formulated as a specific oral dosage form designed for systemic absorption to inhibit 5-alpha-reductase. The technical profile is defined by the physical characteristics of the finished product and the pharmacological potency of the active ingredient.

• Physical Appearance: Blue, oval, film-coated tablets.
• Identification Markings: Imprinted with 'FIN' on one side and '5' on the other to ensure batch and strength verification.
• Packaging Formats: Available in blister strips with standard pack sizes of 28, 30, 50, or 100 tablets per unit.
• Dosage Precision: The 5mg specification is the standard therapeutic dose for BPH management.
• Shelf Life: Typical pharmaceutical shelf life ranges from 24 to 36 months from the date of manufacture, contingent on storage conditions (cool, dry place).
• Bioavailability: Designed for high oral bioavailability with a half-life of approximately 6 to 8 hours in plasma, though tissue levels (prostate) remain elevated for longer periods.

Procurement Recommendation: When evaluating suppliers, request Certificate of Analysis (CoA) samples specifically verifying the 'FIN' and '5' imprinting consistency and film-coating integrity. Ensure the supplier can guarantee the 5mg potency within a tight tolerance range (typically ±5%) to meet regulatory standards for BPH treatment.

2. Industry Compliance and Quality Assurance

As a prescription-only medicine (POM), Finasteride 5mg tablets are subject to stringent regulatory oversight. The product profile indicates authorization under the European Medicines Agency (EMA) framework and specific UK Marketing Authorisation numbers (e.g., PL 08553/0261).

• Regulatory Status: Prescription Only Medicine (POM).
• Manufacturing Standards: Must comply with Good Manufacturing Practice (GMP) standards enforced by the MHRA (UK) and EMA.
• Certification: The product is authorized in EEA member states, implying adherence to ICH (International Council for Harmonisation) guidelines for stability and purity.
• Supply Chain Traceability: Full batch tracking is required from the Marketing Authorisation Holder (e.g., Dr. Reddy's Laboratories) to the final point of sale.
• Safety Warnings: Strict compliance with pregnancy category X warnings (teratogenic risk) is mandatory in labeling and handling protocols.

Procurement Recommendation: Verify that the supplier holds a valid Marketing Authorization (MA) number for the specific jurisdiction of purchase. For B2B procurement, ensure the supplier provides a GMP certificate valid for the last 12 months and a batch-specific CoA confirming the absence of impurities exceeding ICH limits.

3. Cost Efficiency and Integration Capabilities

Finasteride is a generic medication with a mature supply chain, generally offering high cost-efficiency compared to newer, patented urological treatments.

• Cost Structure: As a generic 5mg tablet, unit costs are typically low, driven by established API manufacturing and high-volume production.
• MOQ (Minimum Order Quantity): Typical B2B ranges for finished pharmaceuticals often start at 1,000 to 5,000 units (approx. 50–250 packs of 28), though bulk procurement for hospital chains may require 10,000+ units.
• Lead Time: Standard lead times for generic tablets from UK/EU manufacturers range from 4 to 8 weeks for standard orders, extending to 12 weeks for large-scale custom packaging.
• Integration: The product integrates seamlessly into existing pharmacy inventory management systems (PIMS) and hospital formularies due to its standard packaging (blister strips) and universal ATC code classification.

Procurement Recommendation: Leverage the mature market status to negotiate volume-based discounts. Procurement strategies should prioritize suppliers with stock-on-hand capabilities to mitigate lead time risks. For large institutions, consider multi-year supply agreements to lock in pricing and ensure continuity of supply.

4. Typical Use Cases

Finasteride 5mg tablets are primarily utilized in clinical settings for specific androgen-dependent conditions.

• Benign Prostatic Hyperplasia (BPH): The primary indication for the 5mg dose. Used to reduce prostate volume, improve urinary flow, and prevent acute urinary retention in adult males.
• Androgenetic Alopecia (Hair Loss): While the 1mg dose is standard for hair loss, 5mg tablets are sometimes prescribed off-label or in specific regional protocols for severe cases or when 1mg formulations are unavailable.
• Urological Clinics: Essential stock for primary care and urology departments managing male aging health.
• Dermatology Departments: Used in cases of severe male pattern baldness where combination therapies are required.

Procurement Recommendation: Procurement volumes should be calibrated to local epidemiological data regarding BPH prevalence in the target demographic (typically males over 50). Ensure stock levels align with seasonal demand spikes (e.g., winter months often see increased urological consultations).

5. Long-Term Planning Considerations

The market for Finasteride is stable but faces specific long-term dynamics regarding supply chain resilience and regulatory evolution.

• Market Demand Signals: Demand is driven by an aging global population. The prevalence of BPH increases significantly with age, suggesting a steady, linear growth in demand over the next decade.
• Supply Chain Resilience: As a generic product, the supply chain is generally robust. However, reliance on a single manufacturer (e.g., Dr. Reddy's) poses a risk. Diversification is recommended.
• Regulatory Trends: Increasing scrutiny on pharmaceutical packaging and sustainability (reducing blister waste) may influence future packaging specifications.
• Patent Expiry: The product is fully generic; no patent cliffs are imminent, but price erosion is a long-term trend to anticipate.

Procurement Recommendation: Adopt a "Multi-Source" strategy. Do not rely on a single supplier for more than 60% of total requirements. Plan for a 20% safety stock buffer to account for potential API shortages or regulatory delays. Monitor EMA/MHRA announcements for any changes in labeling requirements regarding teratogenicity warnings.

6. Special Product Recommendations

The following comparison highlights the specific attributes of the Finasteride 5mg tablet relative to general procurement needs.

| Product Type | Best-Fit Buyer | Key Specs | Risk Check | Procurement Advice | | :--- | :--- | :--- | :--- :--- | | Finasteride 5mg Tablets (Generic) | Hospitals, Urology Clinics, Chain Pharmacies | Blue/Oval, 'FIN'/'5' imprint, 28-100 pack sizes, 5mg potency | High (Teratogenicity handling) | Prioritize suppliers with EEA/UK MA numbers; verify GMP compliance. | | Finasteride 1mg Tablets (Generic) | Dermatology Clinics, Retail Pharmacies | Standard imprint, 1mg potency | Medium | Note: 1mg is distinct from 5mg; ensure correct dosage procurement for hair loss indications. | | Bulk API (Finasteride Powder) | Formulation Manufacturers | High purity (>98%), raw powder | High (Handling safety) | Only for in-house manufacturing; requires specialized containment facilities. |

Procurement Recommendation: For clinical buyers, strictly distinguish between 1mg and 5mg formulations. The 5mg tablet is optimized for BPH; using it for hair loss requires specific medical justification. For procurement officers, focus on suppliers who offer blister packaging rather than bulk bottles, as blister packs reduce medication errors and improve patient compliance.

7. Frequently Asked Questions (FAQ)

Q1: Is Finasteride 5mg available over the counter? A: No. It is a Prescription Only Medicine (POM). It requires a valid prescription from a licensed medical practitioner.

Q2: What are the standard pack sizes available for procurement? A: Standard commercial pack sizes typically include blister strips of 28, 30, 50, or 100 tablets. Not all pack sizes may be marketed in every region.

Q3: How do I verify the authenticity of the tablets? A: Authentic tablets are blue, oval, and film-coated. They must be imprinted with 'FIN' on one side and '5' on the other.

Q4: What are the critical safety warnings for procurement staff? A: Finasteride is teratogenic. Pregnant women must not handle crushed or broken tablets. Procurement and storage areas must have protocols to prevent accidental exposure to pregnant personnel.

Q5: What is the typical shelf life of Finasteride 5mg tablets? A: The standard shelf life is typically between 24 and 36 months, provided they are stored in a cool, dry place away from direct sunlight.

Q6: Can this product be used for hair loss? A: While the 5mg dose is primarily for BPH, it is sometimes used off-label for hair loss. However, the 1mg dose is the standard clinical recommendation for androgenetic alopecia.

Q7: Who is the typical Marketing Authorisation Holder for this product? A: Common holders include major pharmaceutical companies such as Dr. Reddy's Laboratories (UK) Ltd, though generic equivalents from other authorized manufacturers exist.

Q8: What is the lead time for bulk orders? A: Typical B2B lead times range from 4 to 8 weeks for standard orders, depending on the supplier's stock levels and the specific packaging requirements.